| Composition of Certain Financial Statement Captions |
|
|
|
|
|
|
|
|
|
(In thousands) |
June 30,
2019 |
|
December 31,
2018 |
Accounts receivable, net: |
|
|
|
Accounts receivable |
$ |
150,414 |
|
|
$ |
145,665 |
|
Less: allowance for doubtful accounts |
(2,127 |
) |
|
(1,758 |
) |
|
$ |
148,287 |
|
|
$ |
143,907 |
|
Inventories, net: |
|
|
|
Consumable supplies |
$ |
22,008 |
|
|
$ |
23,264 |
|
Finished products |
21,481 |
|
|
15,259 |
|
Work in-process |
3,096 |
|
|
2,473 |
|
Raw materials |
4,741 |
|
|
4,259 |
|
Less: inventory reserve |
(3,033 |
) |
|
(2,956 |
) |
|
$ |
48,293 |
|
|
$ |
42,299 |
|
Other current assets and prepaid expenses: |
|
|
|
Taxes recoverable |
18,176 |
|
|
15,708 |
|
Other receivables |
661 |
|
|
2,368 |
|
Prepaid supplies |
10,584 |
|
|
9,693 |
|
Prepaid insurance |
3,878 |
|
|
3,436 |
|
Other |
3,234 |
|
|
3,847 |
|
|
$ |
36,533 |
|
|
$ |
35,052 |
|
Intangible assets, net: |
|
|
|
Customer relationships |
$ |
446,144 |
|
|
$ |
446,296 |
|
Technologies |
340,702 |
|
|
340,729 |
|
Trade names |
50,420 |
|
|
50,404 |
|
Licenses |
5,766 |
|
|
5,766 |
|
Covenants not to compete |
16,321 |
|
|
16,322 |
|
Product registrations |
8,016 |
|
|
7,861 |
|
Other |
5,586 |
|
|
5,613 |
|
Less: accumulated amortization |
(291,649 |
) |
|
(258,539 |
) |
|
$ |
581,306 |
|
|
$ |
614,452 |
|
Accrued expenses: |
|
|
|
Contract liabilities |
$ |
50,388 |
|
|
$ |
63,503 |
|
Employee benefits |
39,453 |
|
|
45,621 |
|
Clinical trials |
9,936 |
|
|
10,401 |
|
Contingent consideration |
5,387 |
|
|
2,375 |
|
Finance leases short-term |
3,031 |
|
|
3,280 |
|
Milestone payment |
4,968 |
|
|
4,871 |
|
Professional fees |
3,317 |
|
|
7,935 |
|
Other |
81,902 |
|
|
65,527 |
|
|
$ |
198,382 |
|
|
$ |
203,513 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(In thousands) |
June 30,
2019 |
|
December 31,
2018 |
Other long-term liabilities: |
|
|
|
Contract liabilities |
$ |
3,665 |
|
|
$ |
27,566 |
|
Line of credit |
65,112 |
|
|
105,198 |
|
Contingent consideration |
20,181 |
|
|
22,162 |
|
Mortgages and other debts payable |
4,500 |
|
|
4,654 |
|
Finance leases long-term |
4,650 |
|
|
5,620 |
|
Other |
29,643 |
|
|
33,768 |
|
|
$ |
127,751 |
|
|
$ |
198,968 |
|
|
| Changes in Goodwill |
The following table summarizes the changes in Goodwill during the six months ended June 30, 2019.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2019 |
(In thousands) |
Balance at January 1 |
|
Foreign exchange and other |
|
Balance at June 30th |
Pharmaceuticals |
|
|
|
|
|
CURNA |
$ |
4,827 |
|
|
$ |
— |
|
|
$ |
4,827 |
|
EirGen |
85,245 |
|
|
(551 |
) |
|
84,694 |
|
FineTech |
— |
|
|
— |
|
|
— |
|
OPKO Chile |
4,614 |
|
|
112 |
|
|
4,726 |
|
OPKO Biologics |
139,784 |
|
|
— |
|
|
139,784 |
|
OPKO Health Europe |
7,545 |
|
|
(49 |
) |
|
7,496 |
|
OPKO Renal |
2,069 |
|
|
— |
|
|
2,069 |
|
Transition Therapeutics |
3,323 |
|
|
137 |
|
|
3,460 |
|
|
|
|
|
|
|
Diagnostics |
|
|
|
|
|
BioReference |
401,821 |
|
|
— |
|
|
401,821 |
|
OPKO Diagnostics |
17,977 |
|
|
— |
|
|
17,977 |
|
OPKO Lab |
32,988 |
|
|
— |
|
|
32,988 |
|
|
$ |
700,193 |
|
|
$ |
(351 |
) |
|
$ |
699,842 |
|
|